US to approve Saudi nuclear deal if kingdom joins Abraham Accords: Trump

US to approve Saudi nuclear deal if kingdom joins Abraham Accords: Trump

US-Iran final nuclear deal

Former President Donald Trump announced that the United States Department of Energy is set to approve a civil nuclear deal with Saudi Arabia, provided the kingdom joins the Abraham Accords. This agreement, designed for non-military purposes, aligns with similar frameworks established with Iran and the UAE. The deal, however, remains subject to Saudi adherence to the Abraham Accords, a diplomatic initiative aimed at normalizing relations between Israel and neighboring Arab nations. The announcement could influence U.S.-Iran relations, introducing new complexities to ongoing negotiations.

Advertisement

Key Takeaways

  • Trump’s statement appears to suggest that Saudi Arabia’s participation in the Abraham Accords is a precondition for the civil nuclear deal, adding a diplomatic layer to the U.S.-Saudi agreement.
  • Market pricing suggests increased uncertainty in the timeline for a U.S.-Iran nuclear agreement, with potential delays or complications introduced by the Saudi deal.
  • Current odds reflect a decreased likelihood of a U.S.-Iran nuclear deal by August 13, 2026, as shown by the recent pricing movements.

What to Watch

Observers should monitor Saudi Arabia’s response to the proposed condition of joining the Abraham Accords and its potential impact on U.S. foreign policy in the region. Developments in U.S.-Iran negotiations remain critical, with attention on any official statements from key negotiators such as Abbas Araghchi or IAEA representatives. Changes in market pricing could occur if new diplomatic actions are taken or if Congress responds to the finalized U.S.-Saudi agreement, suggesting possible shifts in geopolitical strategy.

Get live prediction-market analysis, powered by Vera. Sign up for Vera.

Disclosure: This article was edited by Estefano Gomez. For more information on how we create and review content, see our Editorial Policy.

US to approve Saudi nuclear deal if kingdom joins Abraham Accords: Trump

US to approve Saudi nuclear deal if kingdom joins Abraham Accords: Trump

US-Iran final nuclear deal

Former President Donald Trump announced that the United States Department of Energy is set to approve a civil nuclear deal with Saudi Arabia, provided the kingdom joins the Abraham Accords. This agreement, designed for non-military purposes, aligns with similar frameworks established with Iran and the UAE. The deal, however, remains subject to Saudi adherence to the Abraham Accords, a diplomatic initiative aimed at normalizing relations between Israel and neighboring Arab nations. The announcement could influence U.S.-Iran relations, introducing new complexities to ongoing negotiations.

Advertisement

Key Takeaways

  • Trump’s statement appears to suggest that Saudi Arabia’s participation in the Abraham Accords is a precondition for the civil nuclear deal, adding a diplomatic layer to the U.S.-Saudi agreement.
  • Market pricing suggests increased uncertainty in the timeline for a U.S.-Iran nuclear agreement, with potential delays or complications introduced by the Saudi deal.
  • Current odds reflect a decreased likelihood of a U.S.-Iran nuclear deal by August 13, 2026, as shown by the recent pricing movements.

What to Watch

Observers should monitor Saudi Arabia’s response to the proposed condition of joining the Abraham Accords and its potential impact on U.S. foreign policy in the region. Developments in U.S.-Iran negotiations remain critical, with attention on any official statements from key negotiators such as Abbas Araghchi or IAEA representatives. Changes in market pricing could occur if new diplomatic actions are taken or if Congress responds to the finalized U.S.-Saudi agreement, suggesting possible shifts in geopolitical strategy.

Get live prediction-market analysis, powered by Vera. Sign up for Vera.

Disclosure: This article was edited by Estefano Gomez. For more information on how we create and review content, see our Editorial Policy.